Amgen inks $50M AI drug discovery deal

Amgen, a Thousand Oaks, Calif.-based biopharmaceutical company, will partner with Generate Biomedicines for a research collaboration agreement to discover and create five protein therapeutics for clinical targets.

Read the full post at Becker's Hospital Review - Healthcare News
Vote This Post DownVote This Post Up (No Ratings Yet)
Explore the Archive